Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Navana Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	229.54	184.53	267.77	440.93	66.43	25.78
Cash & Short-Term Investments	229.54	184.53	267.77	440.93	66.43	25.78
Cash Growth	14.73%	-31.09%	-39.27%	563.78%	157.71%	-52.89%
Accounts Receivable	1,461	1,360	996.56	788.15	519.97	434.81
Other Receivables	31.15	16.12	23.57	13.09	27.85	28.08
Receivables	1,492	1,376	1,020	801.24	547.82	462.89
Inventory	1,859	2,086	2,303	1,554	1,170	931.44
Prepaid Expenses	-	-	-	0.95	2.59	1.98
Other Current Assets	1,484	1,536	1,890	1,993	1,109	387.04
Total Current Assets	5,065	5,182	5,480	4,789	2,895	1,809
Property, Plant & Equipment	6,339	6,256	5,746	4,632	4,029	3,389
Long-Term Investments	41.41	34.46	76.92	167.62	159.03	-
Other Intangible Assets	-	0.11	0.33	0.55	0.77	0.99
Other Long-Term Assets	-	-	-	-	-	0
Total Assets	11,445	11,472	11,304	9,590	7,084	5,199

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	188.41	83.92	23.79	44.46	42.65	20.43
Accrued Expenses	633.15	639.15	444.32	298.32	245.36	185.09
Short-Term Debt	3,622	4,283	5,008	4,066	2,682	1,143
Current Portion of Long-Term Debt	42.05	85.76	35.37	18.09	28.13	18.8
Current Portion of Leases	34.11	45.85	43.55	34.72	29.25	34.62
Current Income Taxes Payable	756.92	616.02	451.2	345.48	245.11	141.44
Other Current Liabilities	304.12	292.67	288.36	47.84	14.02	28.31
Total Current Liabilities	5,580	6,047	6,295	4,855	3,287	1,572
Long-Term Debt	112.44	118.66	225.32	120.63	171.39	162.98
Long-Term Leases	108.55	115.35	64.5	89.6	100.72	131.53
Long-Term Deferred Tax Liabilities	323.09	326.71	158.01	152.11	42.36	28.25
Other Long-Term Liabilities	-0	-	-	0	-	-0
Total Liabilities	6,125	6,607	6,743	5,217	3,601	1,895

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	1,074	1,074	1,074	1,074	802.3	802.3
Additional Paid-In Capital	448.17	448.17	448.17	448.17	-	-
Retained Earnings	1,594	1,148	708.02	443.03	204.24	535.83
Comprehensive Income & Other	2,204	2,194	2,331	2,407	2,477	1,966
Shareholders' Equity	5,320	4,865	4,561	4,372	3,483	3,304
Total Liabilities & Equity	11,445	11,472	11,304	9,590	7,084	5,199

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	3,919	4,649	5,377	4,329	3,012	1,491
Net Cash (Debt)	-3,648	-4,430	-5,032	-3,721	-2,786	-1,466
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-33.71	-41.24	-46.85	-37.42	-34.73	-18.27
Filing Date Shares Outstanding	107.42	107.42	107.42	107.42	80.23	80.23
Total Common Shares Outstanding	107.42	107.42	107.42	107.42	80.23	80.23
Working Capital	-515.87	-864.47	-814.39	-65.55	-391.14	237.08
Book Value Per Share	49.53	45.29	42.46	40.71	43.41	41.19
Tangible Book Value	5,320	4,865	4,561	4,372	3,482	3,303
Tangible Book Value Per Share	49.53	45.29	42.46	40.70	43.40	41.17
Land	-	2,483	2,483	2,483	2,483	2,483
Buildings	-	1,700	1,415	1,142	745.82	231.9
Machinery	-	2,330	1,708	985.02	831.81	789.03
Construction In Progress	892.73	821.13	931.72	614.67	403.01	159.04

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error